Daré Bioscience, Inc.
DARE
$2.93
-$0.055-1.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.51M | -4.70M | 12.91M | -6.76M | -5.06M |
| Total Depreciation and Amortization | 6.40K | 9.70K | 15.40K | 10.80K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 735.10K | 685.70K | 740.60K | 1.43M | -493.20K |
| Change in Net Operating Assets | 9.99M | -1.92M | -762.00K | -1.50M | -2.64M |
| Cash from Operations | 5.23M | -5.92M | 12.90M | -6.81M | -8.18M |
| Capital Expenditure | -562.80K | 282.30K | -285.20K | -7.30K | -607.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -562.80K | 282.30K | -285.20K | -7.30K | -607.30K |
| Total Debt Issued | 0.00 | 561.70K | -- | -- | 0.00 |
| Total Debt Repaid | -187.20K | -124.80K | -66.80K | -200.40K | -200.40K |
| Issuance of Common Stock | 55.50K | 0.00 | 183.00K | 215.10K | 785.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -300.00 | -400.00 | -800.00 | -700.00 | 4.72M |
| Cash from Financing | -132.00K | 436.40K | 115.40K | 14.00K | 5.31M |
| Foreign Exchange rate Adjustments | -66.20K | 22.90K | 14.60K | -39.20K | 58.60K |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | 4.47M | -5.18M | 12.75M | -6.85M | -3.42M |